Levelling Up Hull: Assessing and Addressing the Issues, Challenges, and Opportunities for Hull Programme Scope and Outline for Delivery Jun 14, 2021 - Jun 13, 2022
Production of a high-level report outlining the key issues for ‘levelling up’ in Hull, in order to set out the case for foci and investment in Hull by national and local bodies. Producing an initial assessment of the issues, challenges, and opportuni...
Read More about Levelling Up Hull: Assessing and Addressing the Issues, Challenges, and Opportunities for Hull Programme Scope and Outline for Delivery.
All Projects (30)
REMEDI4ALL BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL Sep 1, 2022 - Aug 31, 2027
Osteogenesis imperfecta (OI) causes skeletal fragility, bone pain, sarcopenia and reduced connective tissue resilience, shown as hypermobility and aortic root dilatation (in adults). There is no effective treatment for OI. Current agents only target...
Read More about REMEDI4ALL BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL.
Mortality Risk Prediction of ICU Patients with Sepsis Considering Dynamic Time Series Characteristics under Uncertainty Mar 31, 2023 - Mar 30, 2025
ICU patients with sepsis have rapidly changing conditions and high mortality. Because of it, early prediction and timely intervention are the keys to reducing the risk of death.
The project aims to provide critical care physicians with an int...
Read More about Mortality Risk Prediction of ICU Patients with Sepsis Considering Dynamic Time Series Characteristics under Uncertainty.
BREEZE 2: A randomised controlled trial of a complex intervention to manage breathlessness in pulmonary fibrosis Apr 1, 2024 - Mar 31, 2026
Full trial based on BREEZE feasibility trial
Validation of a mixed digital reporting outcome measure for surgical site infection diagnosis Dec 1, 2022 - Nov 30, 2023
Repeatable identification of infection and personalised care are key priorities for research in vascular surgery, dictated by patients and surgeons alike. However, surgeons are unable to reach a consensus on the best method for diagnosing wound infec...
Read More about Validation of a mixed digital reporting outcome measure for surgical site infection diagnosis.
North Yorkshire Health Determinants Research Collaboration Jan 1, 2024 - Dec 31, 2028
The NIHR Health Determinants Research Collaboration North Yorkshire is a research infrastructure project to build research capacity within North Yorkshire Council. It will embed a strong research culture to generate robust evidence that will inform s...
Read More about North Yorkshire Health Determinants Research Collaboration.
HIKE: Development of a commercial urine test for the earlier detection of endometriosis Jul 1, 2023 - Apr 30, 2024
Endometriosis is a chronic incurable condition that is associated with debilitating pain and subfertility. It affects 190 million women worldwide, takes 8 years to diagnose and costs the UK economy £8.2 billion each year in loss of w...
Read More about HIKE: Development of a commercial urine test for the earlier detection of endometriosis.
The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery Oct 1, 2023 - Sep 30, 2026
Aims
This study aims to investigate the role of a new dressing (DACC) in preventing wound infection follow vascular surgery. This dressing has a special coating that binds to bacteria irreversibly, allowing them to be removed. The DACC dressin...
Read More about The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery.
HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD) Nov 1, 2023 - Oct 31, 2024
This project will combine HYMS/Hull’s biomedical and clinical expertise in vascular biology with Emblation’s track record in bringing medical devices to market to validate and commercialise novel patented microwave probes for treatment of peripheral...
Read More about HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD).
HEIF: QR Policy Development Fund project Jun 1, 2023 - Jul 31, 2023